Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alglucosidase Alfa in Late-Onset Pompe Disease
NCT01288027Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2011
- Primary completion
- Dec 2013
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 4 trial of alglucosidase alfa in Pompe disease, sponsored by Sanofi. Started Jun 2011; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT01288027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288027.